PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
PTC Therapeutics (NASDAQ: PTCT) will report first quarter 2026 financial results on Thursday, May 7, 2026 at 4:30 p.m. ET via a live webcast and conference call.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) will report first quarter 2026 financial results on Thursday, May 7, 2026 at 4:30 p.m. ET via a live webcast and conference call. The company will provide a business update and outlook during the event.
A replay will be available on the company's Investors "Events & Presentations" page for 30 days; phone participation requires advance registration for dial-in details.
Details
News Market Reaction – PTCT
On Apr 22, the day this news came out, PTCT closed 0.31% above the previous close.
Data tracked by StockTitan Argus for the Apr 22 session.
Key Figures
- Earnings call date
- May 7, 2026
- Scheduled Q1 2026 results webcast at 4:30 p.m. ET
- Total 2025 revenue
- $1.731B
- Full-year 2025 results previously reported
- 2025 product & royalty revenue
- $831M
- Full-year 2025
- Year-end 2025 cash
- $1.945B
- Cash balance at end of 2025
- Evrysdi royalty upfront
- $240M
- Royalty sale upfront payment
- Evrysdi milestones
- $60M
- Potential additional royalty sale milestones
- 2025 net income
- $682.6M
- Full-year 2025 net income driven by collaboration payment
- Short interest
- 12.36%
- Reported short interest as a percent of float
Previous Earnings date Reports
-
Announcement of date and time for Q4 and full-year 2025 results webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of the PTC website. A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advance here to receive dial-in details.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-302749730.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.